CA Patent

CA3143257A1 — Viral vector therapy

Assigned to Apellis Pharmaceuticals Inc · Expires 2021-01-14 · 5y expired

What this patent protects

Methods and compositions for combined therapy with viral vectors and complement inhibitors are described.

USPTO Abstract

Methods and compositions for combined therapy with viral vectors and complement inhibitors are described.

Drugs covered by this patent

Patent Metadata

Patent number: CA3143257A1
Jurisdiction: CA
Classification: —
Expires: 2021-01-14
Drug substance claim: No
Drug product claim: No
Assignee: Apellis Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.